… In conclusion, our results show that [ 18 F]β-CFT is a sensitive ligand to detect Parkinson's
disease and to assess its severity. Thus, [ 18 F]β-CFT can be used, not only in the diagnosis, …

… and will result in the residual precursor nor-β-CFT in the final 11 C CFT injection. The aim
of … nor-β-CFT in the 11 C CFT injection on the Parkinson disease (PD) diagnosis results. …

… processes, thereby facilitating the diagnosis and monitoring of therapeutic effects. This …
11C鄄茁鄄CFT PET in PD diagnosis. 揖 Key words铱 Parkinson disease; Radiopharmaceuticals; …

… for the diagnosis of Parkinson’s disease have made … diagnosed by an experienced
Parkinson’s disease specialist according to the clinical diagnostic criteria for Parkinson’s disease …

… Parkinson's disease (PD) has been shown. In this study, we investigate whether a cocaine
analogue, [ 11 C]β-CFT, … All patients fulfilled the clinical diagnosis of probable AD according to …

… The purpose of this study was to use [ 11 C]β-CFT to evaluate the severity of … [ 11 C]β-CFT
mall animal PET images were acquired at different … Criteria for diagnosing Parkinson's disease …

… of L-DOPA uptake for detection of early to advanced stage of Parkinson’s disease in animal
… of progression of dopamine transporter loss in Parkinson’s disease [Abstract]. Mov Disord 15(…

… Parkinson’s disease and the adaptive capacity of the nigrostriatal dopamine system—…
What features improve the accuracy of clinical diagnosis in Parkinson’s disease: A …

… 18F]CFT uptake significantly declines in PD during a 2-year interval following the diagnosis,
… In the present study, the same individuals were studied both at the time of the diagnosis and …

… Parkinson's disease (PD), multiple system atrophy (MSA) and progressive supranuclear palsy
(PSP)—underwent dopamine transporter (DAT) imaging with 11 C-CFT … medical diagnosis …